Decline in the prevalence of antibodies to herpes simplex virus types 1 and 2 among Israeli young adults between 1984 and 2002

Sexually Transmitted Diseases

Volumn 33, Issue 11, 2006, Pages 641-645

  Davidovici, Batya B ^a   Grotto, Itamar ^b,c   Balicer, Ran D ^b,c   Robinson, Noah J ^d   Cohen, Dani ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Medical Corps   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; ISRAEL; MAJOR CLINICAL STUDY; MALE; MILITARY SERVICE; RISK FACTOR; SEROPREVALENCE; SEX RATIO; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH TRANSITION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOGLOBULIN G; ISRAEL; MALE; MILITARY PERSONNEL; SEROEPIDEMIOLOGIC STUDIES;

EID: 33750372858     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000216068.01028.38     Document Type: Article

References (25)

1. Pertel PE, Spear PG. Biology of herpesviruses. In: Holmes KK, Sparling FP, Mardh PA, et al., eds. Sexually Transmitted Diseases, 3rd ed. New York: McGraw-Hill, 1999:269-283.
2. Cowan FM, Johnson AM, Ashley R, et al. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994; 309:1325-1329.
3. Bruisten SM. Genital ulcers in women. Curr Womens Health Rep 2003; 3:288-298.
4. Mindel A. Genital herpes - How much of a public-health problem? Lancet 1998; 351:16-18.
5. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-1111.
6. Xu F, McQuillan G, Kottiri BJ, et al. National seroprevalence and trends in herpes simplex virus type 1 and type 2 infection in the United States, 1988-2000. International Society for Sexually Transmitted Disease Research, Ottawa, Canada, July 27-30, 2003 Congress, pp 58-59.
7. Morris-Cunnington M, Brown D, Pimenta J, et al. New estimates of herpes simplex virus type 2 seroprevalence in England: 'High' but stable seroprevalence over the last decade. Sex Transm Dis 2004;31:243-246.
8. Vyse AJ, Gay NJ, Slomka MJ, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: Implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000;76:183-187.
9. Nilsen A, Myrmel H. Changing trends in genital herpes simplex infection in Bergen, Norway. Acta Obstet Gynecol Scand 2000;79:693-696.
10. Ashley RL. Performance and use of HSV type-specific serology test kits. Herpes 2002; 9:38-45.
11. Davidovici B, Green M, Marouni MJ, et al. Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel. J Infect. In press.
12. Isacsohn M, Smentana Z, Rones ZZ, et al. A sero-epidemiological study of herpes virus type 1 and 2 infection in Israel. J Clin Virol 2002; 24:85-92.
13. Isacsohn M, Bar On E, Yaeger Y, et al. A seroprevalence study of herpes virus type 2 infection in Israeli women: Implications for routine screening. Isr J Med Sci 1994; 30:379-383.
14. Wutzler P, Doerr HW, Farber I, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations - Relevance for the incidence of genital herpes. J Med Virol 2000;61:201-207.
15. Golden MR, Ashley-Morrow R, Swenson P, et al. Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic. Sex Transm Dis 2005; 32:771-777.
16. Green MS, Karsenty E, Slater PE. Recent decline in gonorrhea incidence in Israel: Possible association with the AIDS pandemic. Isr J Med Sci 1988; 24:137-140.
17. Yagupsky P, Schahar A, Peled N, et al. Increasing incidence of gonorrhea in Israel associated with countrywide dissemination of a ciprofloxacin-resistant strain. Eur J Clin Microbiol Infect Dis 2002;21:368-372.
18. Forsgren M, Skoog E, Jeansson S, et al. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: Implications for STD epidemiology. Int J STD AIDS 1995; 5:113-116.
19. Persson K, Mansson A, Jonsson E, Nordenfelt E. Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis 1995; 27:195-199.
20. Dukers NH, Bruisten SM, van den Hoek JA, et al. Strong decline in herpes simplex virus antibodies over time among young homosexual men is associated with changing sexual behavior. Am J Epidemiol 2000; 152:666-673.
21. Klavs I, Rodrigues LC, Wellings K, et al. Increased condom use at sexual debut in the general population of Slovenia and association with subsequent condom use. AIDS 2005; 19:1215-1223.
22. Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143:707-713.
23. Carmel S, Green MS, Slephon R, et al. Gender differences in AIDS-related behavioral changes among 18-19 year olds in a low incidence country. Health Educ Res 1992; 7:217-228.
24. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003; 30:797-800.
25. Samra Z, Scherf E, Dan M. Herpes simplex virus type 1 is the prevailing cause of genital herpes in the Tel Aviv area, Israel. Sex Transm Dis 2003; 30:794-796.